Intracellular delivery of polymeric nanocarriers: a matter of size, shape, charge, elasticity and surface composition.

Recent progress in drug discovery has enabled the targeting of specific intracellular molecules to achieve therapeutic effects. These next-generation therapeutics are often biologics that cannot enter cells by mere diffusion. Therefore, it is imperative that drug carriers are efficiently internalized by cells and reach specific target organelles before releasing their cargo. Nanoscale polymeric carriers are particularly suitable for such intracellular delivery. Although size and surface charge have been the most studied parameters for nanocarriers, it is now well appreciated that other properties, for example, particle shape, elasticity and surface composition, also play a critical role in their transport across physiological barriers. It is proposed that a multivariate design space that considers the interdependence of particle geometry with its mechanical and surface properties must be optimized to formulate drug nanocarriers for effective accumulation at target sites and efficient intracellular delivery.

[1]  Gaudenz Danuser,et al.  Cargo- and adaptor-specific mechanisms regulate clathrin-mediated endocytosis , 2010, The Journal of cell biology.

[2]  Robert B Sim,et al.  Target pattern recognition by complement proteins of the classical and alternative pathways. , 2009, Advances in experimental medicine and biology.

[3]  Y. Koyanagi,et al.  Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy , 1996 .

[4]  Cui Tang,et al.  Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.

[5]  J. Engbersen,et al.  Effect of chemical functionalities in poly(amido amine)s for non-viral gene transfection. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[6]  S. Kannan,et al.  The effect of surface functionality on cellular trafficking of dendrimers. , 2008, Biomaterials.

[7]  Patrick Soon-Shiong,et al.  Protein nanoparticles as drug carriers in clinical medicine. , 2008, Advanced drug delivery reviews.

[8]  Juan B. Blanco-Canosa,et al.  Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. , 2011, ACS nano.

[9]  S. Mitragotri,et al.  Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. , 2011, Advanced drug delivery reviews.

[10]  Efstathios Karathanasis,et al.  Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release. , 2012, ACS nano.

[11]  Mark E. Davis The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. , 2009, Molecular pharmaceutics.

[12]  P. Low,et al.  Discovery and Development of Folic‐Acid‐Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases , 2008 .

[13]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[14]  R. Hancock,et al.  Peptide Antimicrobial Agents , 2006, Clinical Microbiology Reviews.

[15]  Daniel Scherman,et al.  pH-sensitive PEG lipids containing orthoester linkers: new potential tools for nonviral gene delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Iseult Lynch,et al.  Protein-nanoparticle interactions: What does the cell see? , 2009, Nature nanotechnology.

[17]  I. Zuhorn,et al.  Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  D. Thompson,et al.  Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[19]  R K Jain,et al.  Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.

[20]  M. Ferrari,et al.  A Theoretical Model for the Margination of Particles within Blood Vessels , 2005, Annals of Biomedical Engineering.

[21]  D. Mukhopadhyay,et al.  DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis. , 2012, Nano letters.

[22]  Vincent M Rotello,et al.  Effect of nanoparticle surface charge at the plasma membrane and beyond. , 2010, Nano letters.

[23]  Gaurav Sahay,et al.  Endocytosis of nanomedicines. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[24]  R. Jain,et al.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Mauro Ferrari,et al.  Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[26]  P. Janmey,et al.  Tissue Cells Feel and Respond to the Stiffness of Their Substrate , 2005, Science.

[27]  R. Wallis,et al.  Paths reunited: Initiation of the classical and lectin pathways of complement activation. , 2010, Immunobiology.

[28]  M. Belting Heparan sulfate proteoglycan as a plasma membrane carrier. , 2003, Trends in biochemical sciences.

[29]  M. Bryszewska,et al.  Influence of PAMAM dendrimers on human red blood cells. , 2004, Bioelectrochemistry.

[30]  Richard G. W. Anderson,et al.  Caveolin targeting to late endosome/lysosomal membranes is induced by perturbations of lysosomal pH and cholesterol content , 2012, Molecular biology of the cell.

[31]  Nicholas Melosh,et al.  Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation. , 2012, Nano letters.

[32]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[33]  Samir Mitragotri,et al.  Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[34]  A. Prescott,et al.  The coated pit and macropinocytic pathways serve distinct endosome populations , 1994, The Journal of cell biology.

[35]  Christine Allen,et al.  The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. , 2010, Molecular pharmaceutics.

[36]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[37]  Vincent M. Rotello,et al.  Tuning Payload Delivery in Tumour Cylindroids using Gold Nanoparticles , 2010, Nature nanotechnology.

[38]  Li Shi,et al.  Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[39]  Satyajit Mayor,et al.  Pathways of clathrin-independent endocytosis , 2007, Nature Reviews Molecular Cell Biology.

[40]  Thommey P. Thomas,et al.  Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy. , 2004, Bioconjugate chemistry.

[41]  Liangfang Zhang,et al.  Nanoparticle-induced surface reconstruction of phospholipid membranes , 2008, Proceedings of the National Academy of Sciences.

[42]  H. Gresham,et al.  Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice. , 2002, Blood.

[43]  Efstathios Karathanasis,et al.  The effects of particle size, density and shape on margination of nanoparticles in microcirculation , 2011, Nanotechnology.

[44]  V. Fadok,et al.  Apoptotic cell removal , 2001, Current Biology.

[45]  Joseph M DeSimone,et al.  Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[46]  M. Ferrari Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[47]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[48]  H. McMahon,et al.  Mechanisms of endocytosis. , 2009, Annual review of biochemistry.

[49]  H. Shmeeda,et al.  Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[50]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[51]  U. Huth,et al.  Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[52]  G. Mcinerney,et al.  A Differential Role for Macropinocytosis in Mediating Entry of the Two Forms of Vaccinia Virus into Dendritic Cells , 2010, PLoS pathogens.

[53]  A. Ivanov,et al.  Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? , 2008, Methods in molecular biology.

[54]  D. Stolz,et al.  Identification of endothelial cell–surface proteins as targets for diagnosis and treatment of disease , 1996, Nature Medicine.

[55]  P. Choyke,et al.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. , 2008, Nanomedicine.

[56]  M. Conese,et al.  Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[57]  U. Holmskov,et al.  Ficolins and FIBCD1: soluble and membrane bound pattern recognition molecules with acetyl group selectivity. , 2011, Molecular immunology.

[58]  Dong Chen,et al.  The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. , 2010, Biomaterials.

[59]  Huajian Gao,et al.  Cellular uptake of elastic nanoparticles. , 2011, Physical review letters.

[60]  M. Conese,et al.  Gene Transfer by Means of Lipo- and Polyplexes: Role of Clathrin and Caveolae-Mediated Endocytosis , 2006, Journal of liposome research.

[61]  Samir Mitragotri,et al.  Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[62]  J. Kopeček,et al.  Semitelechelic HPMA copolymers functionalized with triphenylphosphonium as drug carriers for membrane transduction and mitochondrial localization. , 2006, Biomacromolecules.

[63]  Antony Thomas,et al.  The shape of things to come: importance of design in nanotechnology for drug delivery. , 2012, Therapeutic delivery.

[64]  T. Gauler,et al.  New targeted treatments in lung cancer--overview of clinical trials. , 2004, Lung cancer.

[65]  Patrick Couvreur,et al.  Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis. , 2007, Biomacromolecules.

[66]  Li Shi,et al.  Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers , 2010, Expert opinion on drug delivery.

[67]  Shan Wang,et al.  Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways. , 2011, Blood.

[68]  Nikolai G. Khlebtsov,et al.  Gold Nanoparticles in Biomedical Applications: Recent Advances and Perspectives , 2012 .

[69]  E. Korn,et al.  PHAGOCYTOSIS OF LATEX BEADS BY ACANTHAMOEBA , 1967, The Journal of cell biology.

[70]  A. Ridley,et al.  Phosphatidylserine (PS) induces PS receptor–mediated macropinocytosis and promotes clearance of apoptotic cells , 2001, The Journal of cell biology.

[71]  Warren C W Chan,et al.  Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.

[72]  P. Roversi,et al.  Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates , 2009, Nature.

[73]  Joseph M DeSimone,et al.  Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. , 2005, Journal of the American Chemical Society.

[74]  Laetitia Gonzalez,et al.  Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[75]  Philip S Low,et al.  Folate receptor-mediated drug targeting: from therapeutics to diagnostics. , 2005, Journal of pharmaceutical sciences.

[76]  A. Maitra,et al.  Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. , 2000, International journal of pharmaceutics.

[77]  H Akita,et al.  Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid , 2007, Gene Therapy.

[78]  Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells , 2008 .

[79]  J. Klein Probing the interactions of proteins and nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[80]  E. Shusta,et al.  Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation , 2007, Pharmaceutical Research.

[81]  Yong Ren,et al.  Plasmid‐Templated Shape Control of Condensed DNA–Block Copolymer Nanoparticles , 2013, Advanced materials.

[82]  Byron Ballou,et al.  Noninvasive imaging of quantum dots in mice. , 2004, Bioconjugate chemistry.

[83]  Silvia Muro,et al.  Endothelial targeting of antibody-decorated polymeric filomicelles. , 2011, ACS nano.

[84]  Mehrdad Hamidi,et al.  Hydrogel nanoparticles in drug delivery. , 2008, Advanced drug delivery reviews.

[85]  Simon Benita,et al.  Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. , 2008, Biomacromolecules.

[86]  J. Huwyler,et al.  Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat. , 1997, The Journal of pharmacology and experimental therapeutics.

[87]  Jinming Gao,et al.  Modeling particle shape-dependent dynamics in nanomedicine. , 2011, Journal of nanoscience and nanotechnology.

[88]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[89]  P. Grutter,et al.  Effect of mechanical properties of hydrogel nanoparticles on macrophage cell uptake , 2009 .

[90]  D. Irvine,et al.  Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.

[91]  Clive G. Wilson,et al.  Blood clearance and organ deposition of intravenously administered colloidal particles. The effects of particle size, nature and shape , 1982 .

[92]  Christian Mühlfeld,et al.  Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles. , 2010, Small.

[93]  R. Müller,et al.  Oligomers of the Arginine-rich Motif of the HIV-1 TAT Protein Are Capable of Transferring Plasmid DNA into Cells* 210 , 2003, The Journal of Biological Chemistry.

[94]  Dai Fukumura,et al.  Cationic Nanoparticles Have Superior Transvascular Flux into Solid Tumors: Insights from a Mathematical Model , 2012, Annals of Biomedical Engineering.

[95]  V. Muzykantov,et al.  Modulation of endothelial targeting by size of antibody-antioxidant enzyme conjugates. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[96]  A. Harvey,et al.  Multimodal analysis of PEI-mediated endocytosis of nanoparticles in neural cells. , 2011, ACS nano.

[97]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[98]  T. Ishida,et al.  Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[99]  Nancy A Monteiro-Riviere,et al.  Mechanisms of quantum dot nanoparticle cellular uptake. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[100]  Erkki Ruoslahti,et al.  Targeting of drugs and nanoparticles to tumors , 2010, The Journal of cell biology.

[101]  Li Shi,et al.  Scalable imprinting of shape-specific polymeric nanocarriers using a release layer of switchable water solubility. , 2012, ACS nano.

[102]  Chung-Yuan Mou,et al.  Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. , 2009, Small.

[103]  Mauro Ferrari,et al.  Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.

[104]  Samuel Zalipsky,et al.  Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. , 2004, Advanced drug delivery reviews.

[105]  Sara Linse,et al.  Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.

[106]  Shinsuke Sando,et al.  A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. , 2004, Journal of the American Chemical Society.

[107]  Joel G Pounds,et al.  Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[108]  D. Irvine,et al.  cell-membrane penetration by monolayer-protected nanoparticles , 2008 .

[109]  Michel Vert,et al.  Biodistribution of Long-Circulating PEG-Grafted Nanocapsules in Mice: Effects of PEG Chain Length and Density , 2001, Pharmaceutical Research.

[110]  P. Couvreur,et al.  Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.

[111]  R. Andreesen,et al.  Phagocytosis of Nanoparticles by Human Immunodeficiency Virus (HlV)-Infected Macrophages: A Possibility for Antiviral Drug Targeting , 1992, Pharmaceutical Research.

[112]  Kenneth A. Dawson,et al.  Protein–Nanoparticle Interactions , 2008, Nano-Enabled Medical Applications.

[113]  Samir Mitragotri,et al.  Polymer particles that switch shape in response to a stimulus , 2010, Proceedings of the National Academy of Sciences.

[114]  Mary E Napier,et al.  The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[115]  R. Parton,et al.  The multiple faces of caveolae , 2007, Nature Reviews Molecular Cell Biology.

[116]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[117]  Walter Hu,et al.  Shape-specific polymeric nanomedicine: emerging opportunities and challenges , 2011, Experimental biology and medicine.

[118]  I. Zuhorn,et al.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.

[119]  Samir Mitragotri,et al.  Spontaneous shape reconfigurations in multicompartmental microcylinders , 2012, Proceedings of the National Academy of Sciences.

[120]  Patrick Soon-Shiong,et al.  Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[121]  Joseph M. DeSimone,et al.  Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.

[122]  Victoria A. Higman,et al.  His-384 Allotypic Variant of Factor H Associated with Age-related Macular Degeneration Has Different Heparin Binding Properties from the Non-disease-associated Form* , 2006, Journal of Biological Chemistry.

[123]  A. Malik,et al.  Protein transport across the lung epithelial barrier. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[124]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[125]  Ning Gu,et al.  Computational investigation of interaction between nanoparticles and membranes: hydrophobic/hydrophilic effect. , 2008, The journal of physical chemistry. B.

[126]  Vladimir R Muzykantov,et al.  Polymeric carriers: role of geometry in drug delivery. , 2008, Expert opinion on drug delivery.

[127]  T. Daniels,et al.  The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. , 2006, Clinical immunology.

[128]  Hongwei Liao,et al.  Biomedical applications of plasmon resonant metal nanoparticles. , 2006, Nanomedicine.

[129]  Ou Chen,et al.  Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration. , 2011, Angewandte Chemie.

[130]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[131]  Robert Langer,et al.  Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers , 2008, Proceedings of the National Academy of Sciences.

[132]  Simon Benita,et al.  Targeting of nanoparticles to the clathrin-mediated endocytic pathway. , 2007, Biochemical and biophysical research communications.

[133]  S. Moghimi Mechanisms of splenic clearance of blood cells and particles : towards development of new splenotropic agents , 1995 .

[134]  Lin Zhu,et al.  Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. , 2012, ACS nano.

[135]  Gustavo Helguera,et al.  The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. , 2006, Clinical immunology.

[136]  Samir Mitragotri,et al.  Particle shape enhances specificity of antibody-displaying nanoparticles , 2013, Proceedings of the National Academy of Sciences.

[137]  Matthew D. McDermott,et al.  The hydrogel template method for fabrication of homogeneous nano/microparticles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[138]  Warren C W Chan,et al.  The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.

[139]  S. Wise Nanocarriers as an emerging platform for cancer therapy , 2007 .

[140]  S Moein Moghimi,et al.  Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering. , 2010, ACS nano.

[141]  M. Michaelis,et al.  Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain , 2006, Journal of Pharmacology and Experimental Therapeutics.

[142]  V. Muzykantov,et al.  Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1. , 2012, ACS nano.

[143]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[144]  Gaurav Sahay,et al.  The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents. , 2010, Biomaterials.

[145]  T. Ishida,et al.  Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. , 2008, International journal of pharmaceutics.

[146]  Kenneth A Dawson,et al.  Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. , 2013, Journal of the American Chemical Society.

[147]  Vladimir P Torchilin,et al.  Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. , 2002, Cancer research.

[148]  Jonathan D. Ashley,et al.  A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes. , 2013, ACS nano.

[149]  Juergen Friedrich,et al.  Spheroid-based drug screen: considerations and practical approach , 2009, Nature Protocols.

[150]  Silvia Muro,et al.  Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[151]  M. Edidin,et al.  Shrinking patches and slippery rafts: scales of domains in the plasma membrane. , 2001, Trends in cell biology.

[152]  Stephanie E. A. Gratton,et al.  The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.

[153]  Jean-Paul Behr,et al.  Intracellular delivery of nanometric DNA particles via the folate receptor. , 2002, Bioconjugate chemistry.

[154]  A. Tsourkas,et al.  Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. , 2008, Biomaterials.

[155]  Tore-Geir Iversen,et al.  Cellular trafficking of quantum dot-ligand bioconjugates and their induction of changes in normal routing of unconjugated ligands. , 2008, Nano letters.

[156]  Taro Shimizu,et al.  PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[157]  E. W. Meijer,et al.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[158]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[159]  Samir Mitragotri,et al.  Red blood cell-mimicking synthetic biomaterial particles , 2009, Proceedings of the National Academy of Sciences.

[160]  Nicholas A Peppas,et al.  Intelligent therapeutics: biomimetic systems and nanotechnology in drug delivery. , 2004, Advanced Drug Delivery Reviews.

[161]  Kai Yang,et al.  Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. , 2010, Nature nanotechnology.

[162]  Samir Mitragotri,et al.  Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. , 2010, Current pharmaceutical design.